Switzerland · Series B startup

Who invested in CorFlow Therapeutics

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$49Mraised across 1 round since 2024, from 1 source

Latest round
Series B, $49MSept 2024
Investors
1
See who backed them

The rounds

  1. Sept 2024
    Series B$49M

    Source recorded

Everyone who backed them

Wellington PartnersVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about CorFlow Therapeutics

Who invested in CorFlow Therapeutics?

CorFlow Therapeutics's investors include Wellington Partners.

How much has CorFlow Therapeutics raised?

CorFlow Therapeutics has raised $49M across 1 round since 2024.

When did CorFlow Therapeutics last raise?

CorFlow Therapeutics's most recent round was a Series B of $49M in Sept 2024.

What was CorFlow Therapeutics's biggest round?

Its most recent round, $49M in Sept 2024, is also its largest on record.

Who backed CorFlow Therapeutics first?

CorFlow Therapeutics's first round on record, in Sept 2024, was backed by Wellington Partners.

What stage is CorFlow Therapeutics at?

CorFlow Therapeutics's latest named round is a Series B, in Sept 2024.

Where is CorFlow Therapeutics based?

CorFlow Therapeutics is based in Switzerland.

Companies like CorFlow Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.